Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Biochemistry
|
August 2, 2011
The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocket
Nootan Pandey, Chaturbhuj A Mishra, Dinesh Manvar, et al.
Archiv Der Pharmazie
|
December 3, 2014
Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase
Gizem Çakir, İlkay Küçükgüzel, Rupa Guhamazumder, et al.
Nucleic Acids Research
|
January 22, 2008
Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors
Neerja Kaushik-Basu, Alain Bopda-Waffo, Tanaji T Talele, et al.
Antiviral Research
|
May 13, 2014
Hepatitis C virus polymerase-polymerase contact interface: significance for virus replication and antiviral design
Alberto José López-Jiménez, Pilar Clemente-Casares, Rosario Sabariegos, et al.
European Journal of Medicinal Chemistry
|
February 4, 2015
Synthesis and biological evaluation of α-aryl-α-tetralone derivatives as hepatitis C virus inhibitors
Dinesh Manvar, Talita de A Fernandes, Jorge L O Domingos, et al.
European Journal of Medicinal Chemistry
|
January 28, 2012
Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives
Daniel B Nichols, Guy Fournet, K R Gurukumar, et al.
Chemical Biology & Drug Design
|
January 15, 2013
Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors
Daniel B Nichols, Raquel A C Leão, Amartya Basu, et al.
Plos Pathogens
|
May 27, 2010
Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture
Erica Silberstein, Kathleen Mihalik, Laura Ulitzky, et al.
European Journal of Medicinal Chemistry
|
November 7, 2012
Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors
Andriy G Golub, K R Gurukumar, Amartya Basu, et al.
Molecules (Basel, Switzerland)
|
March 23, 2013
Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents
Ş Güniz Küçükgüzel, İnci Coşkun, Sevil Aydın, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Biochemistry
|
August 2, 2011
The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocket
Nootan Pandey, Chaturbhuj A Mishra, Dinesh Manvar, et al.
Archiv Der Pharmazie
|
December 3, 2014
Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase
Gizem Çakir, İlkay Küçükgüzel, Rupa Guhamazumder, et al.
Nucleic Acids Research
|
January 22, 2008
Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors
Neerja Kaushik-Basu, Alain Bopda-Waffo, Tanaji T Talele, et al.
Antiviral Research
|
May 13, 2014
Hepatitis C virus polymerase-polymerase contact interface: significance for virus replication and antiviral design
Alberto José López-Jiménez, Pilar Clemente-Casares, Rosario Sabariegos, et al.
European Journal of Medicinal Chemistry
|
February 4, 2015
Synthesis and biological evaluation of α-aryl-α-tetralone derivatives as hepatitis C virus inhibitors
Dinesh Manvar, Talita de A Fernandes, Jorge L O Domingos, et al.
European Journal of Medicinal Chemistry
|
January 28, 2012
Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives
Daniel B Nichols, Guy Fournet, K R Gurukumar, et al.
Chemical Biology & Drug Design
|
January 15, 2013
Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors
Daniel B Nichols, Raquel A C Leão, Amartya Basu, et al.
Plos Pathogens
|
May 27, 2010
Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture
Erica Silberstein, Kathleen Mihalik, Laura Ulitzky, et al.
European Journal of Medicinal Chemistry
|
November 7, 2012
Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors
Andriy G Golub, K R Gurukumar, Amartya Basu, et al.
Molecules (Basel, Switzerland)
|
March 23, 2013
Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents
Ş Güniz Küçükgüzel, İnci Coşkun, Sevil Aydın, et al.
Page
of 7